A Phase IIIb-IV, Multicentre, Randomised, Open-label Study to Characterise the Reactogenicity of Afluria Quad Junior in Children 6 Months to Less than 3 Years, and Afluria Quad in Children 3 Years to Less Than 9 Years Across Three Influenza Seasons

  • Buttery, Jim (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/50633/RCHM-2019 (ERM Project ID: 50633)
NMA SSA Reference Number: SSA/50633/MonH-2019-172419(v1)
Monash Health Ref: RES-19-0000-320X
StatusFinished
Effective start/end date27/05/19 → 26/05/24

Keywords

  • clinical trial
  • influenza
  • child health

Clinical Trial Phase

  • Phase III (a & b)